Aller au contenu

Benoît Cossette

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département des sciences de la santé communautaire

Présentation

Sujets, disciplines ou intérêts de recherche

Gériatrie, Pharmacie, Pharmacoépidémiologie

Diplômes

  • (2015-2017). Postdoctorat. Clinical Pharmacology & Toxicology. McMaster University. Hamilton, Ontario, Canada.
  • (2015-2016). Postdoctorat. Programme de recherche en sciences de la santé. Université de Sherbrooke. Sherbrooke, Quebec, Canada.
  • (2010-2014). Doctorat. Faculté de pharmacie. Université de Montréal. Montreal, Quebec, Canada.
  • (1997-1999). Maîtrise. Faculté de pharmacie. Université de Montréal. Montreal, Quebec, Canada.
  • (1993-1997). Baccalauréat en pharmacie. Faculté de pharmacie. Université de Montréal. Montreal, Quebec, Canada.

Expériences académiques

  • Professeur agrégé (Département des sciences de la santé communautaire). (2017-). Université de Sherbrooke. Sherbrooke, Quebec, Canada.

Financement

  • Subvention. Towards personalised medicine in older people with polypharmacy: Using bioinformatics to understand the mechanism of polypharmacy and deprescribing (submitted for funding). National Health and Medical Research Council (Canberra, Australie). 1 169 729 AUD. (2026-2030).
  • Subvention. Can we classify natural health products and evaluate their impacts on health? A CLSA study using machine learning. Canadian Institutes of Health Research (Ottawa, Canada). 69 848 $. (2026-2027).
    Numéro de subvention : 202510AD6. Voir plus
  • Subvention. Trajectories of care for people living with dementia in Quebec: Improving knowledge using real-world empirical results. Canadian Institutes of Health Research (Ottawa, Canada). 428 400 $. (2025-2029).
    Numéro de subvention : 202503PJT. Voir plus
  • Subvention. Addressing social frailty: developing predictive models to support community actors. Canadian Institutes of Health Research (Ottawa, Canada). 70 000 $. (2025-2026).
    Numéro de subvention : 202410AD7. Voir plus
  • Subvention. Polypharmacy and high-risk medication use in older adults who are lonely, socially isolated and lack social support. Canadian Institutes of Health Research (Ottawa, Canada). 69 994 $. (2025-2026).
    Numéro de subvention : 202410CD5. Voir plus
  • Subvention. Trajectories of social participation and connection according to individual and environmental characteristics in aging adults: Longitudinal analyses of the Canadian Longitudinal Study on Aging (CLSA). Canadian Institutes of Health Research (Ottawa, Canada). 70 000 $. (2025-2026).
    Numéro de subvention : 202410AD9. Voir plus
  • Subvention. PartÂge – participation sociale lors du grand âge : vers la cocréation d’actions et de milieux de vie inclusifs par, pour et avec des citoyens de l’Estrie. Fonds de recherche du Québec (QC, Canada). 600 000 $. (2025-2029).
  • Subvention salariée. Évaluer l’impact de l’usage de médicaments anticholinergiques et sédatifs chez les aînés. Fonds de recherche du Québec (Québec, Canada). 265 407 $. (2024-2027).
  • Subvention. Anticholinergic and sedative medications use in the Canadian population. Canadian Institutes of Health Research (Ottawa, Canada). 69 980 $. (2024-2025).
    Numéro de subvention : 202310ACD. Voir plus
  • Subvention. Vieillir chez soi : Soutenir les residences pour personnes ainees dans l'adoption des meilleures pratiques pour eviter l'entree en hebergement de soins de longue duree. Canadian Institutes of Health Research (Ottawa, Canada). 108 156 $. (2023-2024).
    Numéro de subvention : 202210PO4. Voir plus
  • Subvention. Impact in older adults of reducing anticholinergic and sedative medication burden on physical function measured by clinical digital phenotyping in lab and real-life environments. Canadian Institutes of Health Research (Ottawa, Canada). 631 126 $. (2022-2025).
    Numéro de subvention : 202203PJT. Voir plus
  • Subvention. Soulager la douleur chronique chez les aines a l'aide de la stimulation transcranienne par courant direct. Canadian Institutes of Health Research (Ottawa, Canada). 569 926 $. (2022-2025).
    Numéro de subvention : 202109PJT. Voir plus
  • Subvention. Collaboration entre les services gériatriques ambulatoires spécialisés pour les personnes vivant avec un trouble neurocognitif majeur. Fonds de recherche du Québec (QC, Canada). 750 000 $. (2022-2025).
  • Subvention. Canadian Longitudinal Study on Aging. Canadian Institutes of Health Research (Ottawa, Canada). 48 350 000 $. (2021-2027).
    Numéro de subvention : 202102LSA. Voir plus
  • Subvention. Étude longitudinale canadienne sur le vieillissement (ÉLCV) cerveaux en santé, inititaive vieillir en santé. Weston Family Foundation (Toronto, Canada). 12 240 322 $. (2021-2028).
  • Subvention. Canadian Longitudinal Study on Aging (CLSA) COVID-19 research platform: studying the impact of the COVID-19 pandemic on cognitive and brain health. Weston Brain Institute (ON, Canada). 161 155 $. (2021-2024).
  • Subvention. Solution informatique pour faciliter les communications d’une trajectoire de soins pharmaceutiques chez les aînés. MEDTEQ+ (QC, Canada). 479 000 $. (2021-2023).
  • Subvention. Understanding the accumulation of multiple chronic diseases and multiple prescribed medications and the influence on the experience of aging among adults and older adults in Canada. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2021-2022).
    Numéro de subvention : 202010PJ2. Voir plus
  • Subvention. Canadian Longitudinal Study on Aging (CLSA): Building COVID-19 Platform for Research in Canada. Canadian Institutes of Health Research (Ottawa, Canada). 1 199 987 $. (2020).
    Numéro de subvention : 202011CMO. Voir plus
  • Subvention. Détermination de la démence et surveillance des facteurs de risque dans l'Étude longitudinale canadienne sur le vieillissement (ELCV). Public Health Agency of Canada (ON, Canada). 999 526 $. (2020-2024).
  • Subvention. Using the CLSA Platform to study the seroepidemiology of SARS-CoV-2 infection in older Canadians (CLSA COVID-19 Study). Public Health Agency of Canada (ON, Canada). 4 028 508 $. (2020-2021).
  • Subvention. PUPPY Study - Problems Coordinating and Accessing Primary Care for Attached and Unattached Patients Exacerbated During the COVID-19 Pandemic Year: A Longitudinal Mixed Methods Study with Rapid Reporting and Planning for the Road Ahead. Canadian Institutes of Health Research (Ottawa, Canada). 407 552 $. (2020-2021).
    Numéro de subvention : 202005VR4. Voir plus
  • Subvention. The CUP Study: Comparative analysis of centralized waitlist effectiveness, policies, and innovations for Connecting Unattached Patients to primary care providers. Canadian Institutes of Health Research (Ottawa, Canada). 613 488 $. (2019-2022).
    Numéro de subvention : 201903PJT. Voir plus
  • Subvention. La pharmacoépidémiologie au service de l'usage optimal des médicaments chez les aînés (Chercheur boursier Junior 1). Fonds de recherche du Québec (QC, Canada). 350 888 $. (2019-2023).
  • Subvention. Real-world evaluation of the efficacy, safety and cost- effectiveness of statins for primary prevention of cardiovascular disease among the elderly – a causal perspective to treatment trajectory. Instituts de recherche en santé du Canada (Ottawa, Canada). 279 225 $. (2019-2022).
  • Subvention. Optimiser les pratiques, les usages, les soins et les services – Antipsychotiques (OPUSAP). Centre for Aging + Brain Health Innovation (Toronto, Canada). Optimiser les pratiques, les usages, les soins et les services – Antipsychotiques (OPUSAP). 150 000 $. (2018-2019).
  • Subvention. Trajectoire de soins pharmaceutiques chez les personnes âgées – cohorte prospective. Fonds de Recherche du Québec - Santé (Montreal, Canada). 639 436 $. (2018-2021).
    Numéro de subvention : 279741. Voir plus
  • Subvention. Optimiser les pratiques, les usages, les soins et les services – Antipsychotiques (OPUSAP). Canadian Foundation for Healthcare Improvement (ON, Canada). 1 200 000 $. (2017-2020).
  • Subvention. Optimiser les pratiques, les usages, les soins et les services – Antipsychotiques (OPUSAP). Ministère de la Santé et des Services Sociaux (Québec, Canada). 1 200 000 $. (2017-2020).
  • Bourse. Bourse de formation postdoctorale. Fonds de recherche du Québec (QC, Canada). 78 646 $. (2015-2017).
  • Subvention. Canadian Longitudinal Study on Aging. Canadian Institutes of Health Research (Ottawa, Canada). 58 805 672 $. (2014-2021).
    Numéro de subvention : 201406LSA. Voir plus
  • Subvention. Amélioration de la prescription médicamenteuse pour les aînés hospitalisés. Faculté de médecine et des sciences de la santé, Université de Sherbrooke (QC, Canada). 50 000 $. (2014-2016).
  • Bourse. Bourse de formation au doctorat. Fonds de recherche du Québec (QC, Canada). 117 969 $. (2012-2014).
  • Subvention. Identification de nouveaux tératogènes, médicaments foeto-toxiques: épidémiologie, pharmacologie, toxicité et mécanismes d'action/. Réseau Québécois de Recherche sur les Médicaments (QC, Canada). 120 000 $. (2011-2013).

Publications

Articles

  • Keren Pelen, Patrick Boissy, Karina Lebel, Alexandra Mayhew, Marla K Beauchamp, Lauren E Griffith, Megan E O’Connell, Sarah N Hilmer, Marie-Laure Baroud, Caroline Sirois, Frank Moriarty, Jean-Philippe Turcotte, Lisa Kouladjian O’Donnell, Kathryn Nicholson, Benoit Cossette. (2026). Association between anticholinergic and sedative medications and physical functioning: data from the Canadian longitudinal study on aging (CLSA). European Journal of Clinical Pharmacology. DOI
  • Marie‐Pier Villemure, Benoît Cossette, Pierre‐Vincent Breault‐Ruel, Alexandre Camirand, Catherine Hudon. (2025). Structured Clinical Tools for Periodic Health Assessment of Older Adults in Primary Care: A Scoping Review. Health Science Reports. DOI
  • Magalie Gagnon, Jason Robert Guertin, Caroline Sirois, Marc Simard, Benoît Cossette, Marie-Eve Gagnon. (2025). Cost trends of potentially inappropriate medications among older adults between 2012 and 2021 in Quebec, Canada: a population-based repeated cross-sectional study. BMC Geriatrics. DOI
  • Cossette B, Boissy P, Milot M-H, Hilmer SN, Kouladjian O'Donnell L, Gnjidic D, Sirois C, Mangin D, Ricard G, Isenor J, Roy-Petit J, Abdulrazak B, Tousignant M, Lebel K. (2025). Feasibility of measuring physical function by wearable devices during deprescribing of anticholinergic and sedative medications. Canadian Journal on Aging. DOI
  • Ouraou R, Cossette B, Perron M-È, Hudon C. (2025). Pharmacists' role in interventions addressing excessive polypharmacy: a scoping review. International Journal of Clinical Pharmacy. DOI
  • *Pelen-Tobar K, *Hagenimana W-B, Baroud M-L, Chiu Y, Chebbihi H, Lebel K, Boissy P, Cossette B. (2025). Prevalence and factors associated with anticholinergic medication use incommunity-dwelling older adults: a systemic review. International Journal of Clinical Pharmacy. DOI
  • Nicholson K, Salerno J, Borhan S, Cossette B, Guenter D, Vanstone M, Queenan J, Greiver M, Howard M, Terry AL, Williamson T, Griffith LE, Fortin M, Stranges S, Mangin D. (2025). The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: a cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). PLoS One. DOI
  • Miceline Mésidor, Caroline Sirois, Jason Robert Guertin, Mireille E. Schnitzer, Bernard Candas, Claudia Blais, Benoit Cossette, Paul Poirier, James M. Brophy, Lisa Lix, Mina Tadrous, Awa Diop, Denis Hamel, Denis Talbot. (2024). Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation. Journal of Clinical Epidemiology. DOI
  • Cossette B, Griffith L, Emond PD, Mangin D, Moss L, Boyko J, Nicholson K, Ma J, Raina P, Wolfson C, Kirkland S, Dolovich L. (2024). Drug and natural health product data collection and curation in the Canadian Longitudinal Study on Aging. Canadian Journal on Aging (on line Feb 2024). DOI
  • Frieden P, Gagnon R, Bénard É, Cossette B, Bergeron F, Talbot D, Guertin JR. (2024). Strategies aiming to improve statin therapy adherence in older adults: a systematic review. BMC Geriatrics.
  • Gregory MA, Schaeffer MJ, Reeves JTH, Griffith LE, Wolfson C, Basta NE, McMillan JM, Kirkland S, Raina P, Paterson TSE, on behalf of the Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2024). The effects of cognitive ability, mental health, and self-quarantining on functional ability of older adults during the COVID-19 pandemic: results from the Canadian Longitudinal Study on Aging. Journal of Geriatic Psychiatry and Neurology. DOI
  • McInerney B, Cross AJ, Alderman CP, Bhat R, Boyd CM, Brandt N, Cossette B, Desforges K, Dowd LA, et al. (2024). Top 10 signs and symptoms of psychotropic adverse drug events to monitor in residents of long-term care facilities. Journal of the American Medical Directors Association. DOI
  • Jennifer E. Isenor, Benoit Cossette, Andrea L. Murphy, Mylaine Breton, Maria Mathews, Lauren R. Moritz, Richard Buote, Lisa McCarthy, Lisa Woodill, Bobbi Morrison, Line Guénette, Emily Gard Marshall. (2023). Community pharmacists’ expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study. International Journal of Clinical Pharmacy. DOI
  • Lane J, Manceau LM, Massuard M, Couturier Y, Cossette B, Ricard J, Viscogliosi C, Déry V, Gauthier P. (2023). Déterminants du succès d'une démarche provinciale d'usage optimal des antipsychotiques chez les résidents en soins de longue durée selon les acteurs clés impliqués dans l'implantation. Revue canadienne du vieillissement. DOI
  • Marshall EG, Stock D, Buote R, Andrew MK, Breton M, Cossette B, Green ME, Isenor JE, Mathews M, MacKenzie A, Martin-Misener R, McDougall B, Mooney M, Moritz LR. (2023). Emergency department utilization and hospital admissions for ambulatory care sensitive conditions among people seeking a primary care provider during the COVID-19 pandemic. CMAJ Open. DOI
  • Kirkland SA, Griffith LE, Oz UE, Thompson M, Wister A, Kadowaki L, Basta NE, McMillan J, Wolfson C, Raina P, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2023). Increased prevalence of loneliness and associated risk factors during the COVID-19 pandemic: findings from the Canadian Longitudinal Study on Aging (CLSA). BMC Public Health. DOI
  • Diop A, Sirois C, Guertin J, Schnitzer M, Candas B, Cossette B, Brophy J, Mésidor M, Blais C, Hamel D, Tadrous M, Lix L, Talbot D. (2023). Marginal structural models with latent class growth analysis of treatment trajectories: statins for primary prevention among adults. Statistical Methods in Medical Research. DOI
  • Du Rubeis V, Gonzalez A, De Groh M, Jiang Y, Oz UE, Tarride J-E, Basta NE, Kirkland S, Wolfson C, Griffith LE, Raina P, Anderson LN, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2023). Obesity and adverse childhood experiences in relation to stress during the COVID-19 pandemic: an analysis of the Canadian Longitudinal Study on Aging. International Journal of Obesity. DOI
  • Griffith LE, Beauchamp MK, McMillan J, Borhan S, Oz UE, Wolfson C, Kirkland S, Basta NE, Thompson M, Raina P, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2023). Persistent of COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA). Communications Medicine. DOI
  • Mayhew AJ, Hogan D, Raina P, Wolfson C, Costa AP, Jones A, Kirkland S, O'Connell M, Taler V, Smith EE, Liu-Ambrose T, Ma J, Thompson M, Wu C, Chertkow H, Griffith LE, CLSC Memory Study Working Group (Cossette B). (2023). Protocol for validating an algorith to identify neurocognitive disorders in Canadian Longitudinal Study on Aging participants: an observational study. BMJ Open. DOI
  • Benoit Cossette, Marie-Andrée Bruneau, Michèle Morin, Suzanne Gilbert, Diane Boyer, Tanya Mac Donald, Andrée-Anne Rhéaume, Nouha Ben Gaied, Marilyn Tousignant, Jean-Philippe Turcotte, Claudie Rodrigue, Rachel Rouleau, Yves Couturier. (2022). Optimizing Practices, Use, Care, and Services–Antipsychotics (OPUS-AP) in Long-Term Care Centers in Quebec, Canada: A Successful Scale-Up. Journal of the American Medical Directors Association. DOI
  • Benoit Cossette, Geneviève Ricard, Rolande Poirier, Suzanne Gosselin, Marie‐France Langlois, Philippe Imbeault, Mylaine Breton, Yves Couturier, Caroline Sirois, Mélissa Lessard‐Beaudoin, Claudie Rodrigue, Julie Teasdale, Jean‐Philippe Turcotte, Louise Mallet. (2022). Pharmacist‐led transitions of care between hospitals, primary care clinics, and community pharmacies. Journal of the American Geriatrics Society. DOI
  • Levasseur M, Naud D, Presse N, Delli-Colli N, Boissy P, Benoît C, Couturier Y, Genesse JC. (2022). Aging all over the place : A multidisciplinary framework for advancing perspectives of older adults within their communities. Quality in Ageing and Older Adults. DOI
  • Beauchamp MK, Joshi D, McMillan J, Erbas Oz U, Griffith LE, Basta NE, Kirkland S, Wolfson C, Raina P, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2022). Assessment of functional mobility after COVID-19 in adults aged 50 years or older in the Canadian Longitudinal Study on Aging. JAMA Network Open. DOI
  • Breuker C, Teasdale J, Mallet L, Ricard G, Turcotte J-P, Gosselin S, Langlois M-F, Imbeault P, Breton M, Couturier Y, Sirois C, Cossette B. (2022). Communication between hospitals, Family Medicine Groups and community pharmacists during transitions of care interventions for older adults. Research in Social and Administrative Pharmacy. DOI
  • Griffith L, McMillan J, Hogan D, Pourfarzaneh S, Anderson LN, Kirland S, Basta N, van den Heuvel ER, Raina P,, the Canadian Longitudinal Study on Aging Team (Cossette B). (2022). Frailty and the impacts of the COVID-19 pandemic on community-living older adults: an analysis of data from the Canadian Longitudinal Study on Aging (CLSA). Age and Ageing. DOI
  • Couturier Y, Lanneville D, Lane J, Bruneau MA, Morin M, Gilbert S, Boyer D, MacDonald T, Ben Gaied N, Cossette B. (2022). Implementation conditions leading to the scale-up of an innovation involving the optimal use of antipsychotics in long-term care centers: The Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) program. Research in Social & Administrative Pharmacy. DOI
  • Wister A, Li L, Mitchell B, Wolfson C, McMillan J, Griffith LE, Kirkland S, Raina P, on behalf of the Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2022). Levels of depression and anxiety among informal caregivers during the COVID-19 pandemic: A study based on the Canadian Longitudinal Study on Aging. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. DOI
  • Wister A, Li L, Cosco TD, McMillan J, Griffith LE, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2022). Multimorbidity resilience and COVID-19 pandemic self-reported impact and worry among older adults: a study based on the Canadian Longitudinal Study on Aging (CLSA). BMC Geriatrics. DOI
  • Ouellet N, Bergeron A-S, Gagnon E, Cossette B, Labrecque CA, Sirois C. (2022). Prescribing and deprescribing in very old age: perceptions of very old adults, caregivers and health professionals. Age and Ageing. DOI
  • Khattar J, Griffith LE, Jones A, Rubein D, De Groh M, Jiang Y, Basta NE, Kirkland S, Wolfson C, Raina P, Anderson LN, Canadian Longitudinal Study on Aging (CLSA) Team (Cossette B). (2022). Symptoms of depression and anxiety, and unmet healthcare needs in adults during the COVID-19 pandemic: a cross-sectional study from the Canadian Longitudinal Study on Aging. BMC Public Health. DOI
  • *Khalilipalandi S, Breton M, Breuker C, Cossette B. (2022). Transitions de soins pharmaceutiques chez les personnes âgées : une évaluation de la mise en place. Journal de santé publique. DOI
  • Emily Gard Marshall, Mylaine Breton, Benoit Cossette, Jennifer Isenor, Maria Mathews, Caitlyn Ayn, Mélanie Ann Smithman, David Stock, Eliot Frymire, Lynn Edwards, Michael Green. (2021). Problems in Coordinating and Accessing Primary Care for Attached and Unattached Patients Exacerbated During the COVID-19 Pandemic Year (the PUPPY Study): Protocol for a Longitudinal Mixed Methods Study. JMIR Research Protocols. DOI
  • Gaboury I, Breton M, Perreault K, Bordeleau F, Descôteaux S, Maillet L, Hudon C, Couturier Y, Duhoux A, Vachon B, Cossette B, Rodrigues I, Poitras ME, Loignon C, Vasiliadis HM. (2021). Interprofessional advanced access - a quality improvement protocol for expanding access to primary care services. BMC Health Services Research. DOI
  • Cossette B, Ricard G, Poirier R, Gosselin S, Langlois M-F, Breton M, Sirois C, Rodrigue C, Lessard-Beaudoin M, Teasdale J, *Piché B, *Khalilipalandi S, Trottier L, Mallet L. (2021). Pharmacist-led transitions of care for older adults at risk of drug-related problems: a feasibility study. Research in Social and Administrative Pharmacy. DOI
  • Benoit Cossette, Marie-Andrée Bruneau, Yves Couturier, Suzanne Gilbert, Diane Boyer, Jacques Ricard, Tanya McDonald, Karine Labarre, Véronique Déry, Marcel Arcand, Claudie Rodrigue, Andrée-Anne Rhéaume, Sylvie Moreault, Catherine Allard, Maude-Émilie Pépin, Olivier Beauchet. (2020). Optimizing Practices, Use, Care and Services–Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices. Journal of the American Medical Directors Association. DOI
  • Benoit Cossette, Ryeyan Taseen, Jacynthe Roy-Petit, Marie-Pier Villemure, Martine Grondin, Geneviève Ricard, François Goyer, Caroline Blanchard, Thomas Joly-Mischlich, Jean-François Éthier. (2019). A pharmacist-physician intervention model using a computerized alert system to reduce high-risk medication use in primary care. European Journal of Clinical Pharmacology. DOI
  • Raina P, Wolfson C, Kirkland S, Griffith LE, Balion C, Cossette B, Dionne I, Hofer S, Hogan D, Van Den Heuvel ER, Liu-Ambrose T, Menec V, Mugford G, Patterson C, Payette H, Richards B, Shannon H, Sheets D, Taler V, Thompson M, Tuokko H, Wister A, Wu C, Young L. (2019). Cohort profile: The Canadian Longitudinal Study on Aging (CLSA). International Journal of Epidemiology. DOI
  • Cossette B, Bagna M, Sene M, Sirois C, *Lefebvre G, *Germain O, Morais J, Gaudreau P, Payette H. (2017). Association between anticholinergic drug use and health-related quality of life in community-dwelling older adults. Drugs and Aging. DOI
  • Cossette B, Éthier JF, Joly-Mischlich T, Bergeron J, Ricard G, Brazeau S, Caron M, *Germain O, Payette H, Kaczorowski J, Levine M. (2017). Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial. European Journal of Clinical Pharmacology.
  • Samoilenko M, Blais L, Cossette B, Forget A., Lefebvre G. (2016). Assessing the dose-response relationship between maternal use of inhaled corticosteroids therapy and birth weight: a generalized propensity score approach. Journal of Observational Studies.
  • Cossette B, Bergeron J, Ricard G, Éthier JF, Joly-Mischlich T, Levine M, Sene M, Mallet L, Lanthier L, Payette H, Rodrigue MC, Brazeau S. (2016). Knowledge translation strategy to reduce the use of high-risk drugs in elderly inpatients. Journal of the American Geriatrics Society.
  • Battista MC, Boutin M, Venne P, Blais L, Bérard A, Lacroix M, Patenaude J, Guillemette L, Cossette B, Hivert MF, Auray-Blais C. (2016). Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood. Bioanalysis.
  • *Arvisais K, *Bergeron-Wolff S, *Bouffard C, *Michaud AS, Bergeron J, Mallet L, Brazeau S, Joly-Mischlich T, Bernier-Filion N, Lanthier L, Ricard G, Rodrigue MC, Cossette B. (2015). A pharmacist--physician intervention model using a computerized alert system to reduce high-risk medication Use in elderly inpatients. Drugs & Aging.
  • Rousseau MP, Beauchesne MF, Naud AS, Leblond J, Cossette B, Lanthier L, Grondin F, Bernier F. (2014). An interprofessional qualitative study of barriers and potential solutions for the safe use of insulin in the hospital setting. Canadian Journal of Diabetes.
  • Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey E, Blais L. (2014). Relative perinatal safety of salmeterol versus formoterol and fluticasone versus budesonide use during pregnancy. Annals of Allergy, Asthma & Immunology.
  • Cossette B,Beauchesne MF, Forget A, Lemière C, Larivée P, Rey E, Couturier M, Rodrigue C, Blais L. (2014). Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting. Respiratory Medicine.
  • Cossette B, Forget A, Beauchesne MF, Rey E, Lemière C, Larivée P, Battista MC, Blais L. (2013). Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax.
  • Cossette B, Pelletier ME, Carrier N, Turgeon M, Leclair C, Charron P, Echenberg D, Fayad T, Farand P. (2010). Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative. The Annals of Pharmacotherapy.
  • Nault V, Beaudoin M, Thirion DJ, Gosselin M, Cossette B, Valiquette L. (2008). Antimicrobial stewardship in acute care centres: A survey of 68 hospitals in Quebec. The Canadian Journal of Infectious Diseases & Medical Microbiology / Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada.
  • Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. (2008). Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clinical Infectious Diseases.
  • Valiquette L, Cossette B, Garant MP, Diab H, Pépin J. (2007). Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clinical Infectious Diseases.
  • Pépin J, Valiquette L, Cossette B. (2005). Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ : Canadian Medical Association Journal.

Articles de conférence

  • Marie-Laure Baroud, Karina Lebel, Benoit Cossette. (2026). Association entre la charge médicamenteuse anticholinergique et sédative et les paramètres dynamiques de marche chez les aînés : une étude transversale. DOI
  • Willy-Brad Hagenimana, Benoit Cossette, Yohann Moanahere Chiu. (2026). Association entre l’usage des médicaments anticholinergiques et sédatifs et le sommeil des participants de l’Étude longitudinale canadienne sur le vieillissement. DOI
  • Dylan Bonnan, Catherine Lamoureux-Lamarche, Mylaine Breton, Benoit Cossette. (2026). Du GAP au pharmacien communautaire : profil et trajectoire des personnes aînées orphelines en Montérégie. DOI

Autres contributions

Cours enseignés ou supervisés à l'UdeS

  • PHR607 - Introduction à l'épidémiologie en pharmacologie. (2023-2026). (2CR).

Présentations

  • Cossette B. (2023). Deprescribing older adults' medications: Canadian experiences in the community and long-term care settings. Sydney, Australia & Australian Deprescribing Network. Kolling Institute, Royal North Shore Hospital. Hybrid even, Sydney. Australie.
  • Cossette B. (2023). Optimizing Practices, Use, Care and Services - Antipsychotics (OPUS-AP) in long-term care centers in Québec, Canada: a strategy for best practices. Centre for Medicine Use and Safety. Monash University. Évènement hybride, Melbourne. Australie.
  • Cossette B. (2022). Optimising practices use and services -- Antipsychotics (OPUS-AP) during session: I want to deprescribe but how do I do it? Clinical pearls for deprescribing. Canadian Geriatrics Society, 41st Annual Scientific Meeting 2022, Virtual event. Canada.
  • Cossette B, Breuker C. (2022). Transitions de soins et soins pharmaceutiques de Sherbrooke à Montpellier. Rencontres Montpellier-Sherbrooke. Symposium hybride, Montpellier. France.
  • Cossette B. (2022). Transitions de soins pharmaceutiques chez les aînés. Congrès des pharmaciens d'Occitanie (ADPHSO-LAROPHA). Évènement virtuel, Gruissan. France.
  • Cossette B, Couturier Y, Gilbert S, Boyer D, Ricard J, MacDonald T, Arcand M, Morin M, Tousignant M E, Rhéaume A, Turcotte J-P, Bruneau M-A. (2020). Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP): a phase 2 scale-up to 129 Long-term Care (LTC) centers in Quebec, Canada. Alzheimer's Association International Conference (Online event, oral presentation). Pays-Bas.
  • Cossette B, Couturier Y, Gilbert S, Boyer D, Ricard J, MacDonald T, Arcand M, Morin M, Tousignant M E, Rhéaume A, Turcotte J-P, Bruneau M-A. (2020). Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP): a phase 2 scale-up to 129 Long-term Care (LTC) centers in Quebec, Canada (Best Abstract Awardee in the Category "Optimizing Prescribing Interventions"). The American Geriatrics Society (AGS) Annual Scientific Meeting [Meeting and oral presentation canceled due to COVID-19]. États-Unis.
  • Cossette B, Éthier, J-F, Joly-Mischlich T, Bergeron J, Ricard G, Brazeau S, Caron M, *Germain O, Payette H, Kaczorowski J, Levine M. (2017). Reduction in potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial. American Geriatrics Society Annual Meeting / Congrès annuel de l'AGS, San Antonio. États-Unis.

Divers

  • Emily Gard Marshall, Mylaine Breton, Benoit Cossette, Jennifer Isenor, Maria Mathews, Caitlyn Ayn, Mélanie Ann Smithman, David Stock, Eliot Frymire, Lynn Edwards, Michael Green. (2021). Problems in Coordinating and Accessing Primary Care for Attached and Unattached Patients Exacerbated During the COVID-19 Pandemic Year (the PUPPY Study): Protocol for a Longitudinal Mixed Methods Study (Preprint).
  • Emily Gard Marshall, Mylaine Breton, Benoît Cossette, Jennifer E Isenor, Maria Mathews, Caitlyn Ayn, Mélanie Ann Smithman, David Stock, Eliot Frymire, Lynn Edwards, Michael Green. (2021). The PUPPY Study – Protocol for a Longitudinal Mixed Methods Study Exploring Problems Coordinating and Accessing Primary Care for Attached and Unattached Patients Exacerbated During the COVID-19 Pandemic Year.
  • Cossette B, Mallet L. (2018). La déprescription : un aperçu. Vivre en santé en mode mieux-être.